Traps and pitfalls in evaluating a meta-analysis: rebuttal to the letter by Szczesniak et al.

Abstract

Get full access to this article

View all access options for this article.

References

Szczesniak A, Gorny B, Kowalewski M, et al. Things to avoid in meta-analysis. Eur J Prev Cardiol 2013. [Epub ahead of print 25 March 2013].

Lupi

Rognoni

Secco

. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5834 patients. Eur J Prev Cardiol, 2012. [Epub ahead of print].

Dou

Han

. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Chin Med J 2011; 124: 811–816.

Windecker

Serruys

Wandel

. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008; 372: 1163–1173.

Rognoni

Santagostino

Sansa

. Regarding ‘Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review’. EuroIntervention 2012; 8: 642–643.